Meeting
2023 ASCO Gastrointestinal Cancers Symposium
A novel immune monitoring platform for patients with gastrointestinal cancer.
Authors
Mojun Zhu
Mayo Clinic, Rochester, MN;
Mojun Zhu , Wen Wee Ma , Harry H. Yoon , Joleen M. Hubbard , Robert R. McWilliams , Haidong Dong
Disclaimer
This material on this page is ©2024 American Society of Clinical Oncology, all rights reserved. Licensing available upon request. For more information, please contact licensing@asco.org
Poster Details
Session Type
Poster Session
Session Title
Poster Session A: Cancers of the Esophagus and Stomach and Other GI Cancers
Track
Esophageal and Gastric Cancer,Other GI Cancer
Sub Track
Translational Research
Citation
J Clin Oncol 41, 2023 (suppl 4; abstr 424)
DOI
10.1200/JCO.2023.41.4_suppl.424
Abstract #
424
Poster Bd #
J8
Abstract Disclosures
Funded by Conquer Cancer
Similar Posters
Poster
2024 ASCO Genitourinary Cancers Symposium
Effect of camelid B7-H3 tri-specific killer engagers on natural killer cells in patients with prostate cancer.
First Author: Nicholas Zorko
Poster
2017 ASCO Annual Meeting
Effects of age, immune landscape, and response to trastuzumab (H) in HER-2 positive (HER2+) breast cancer in NCCTG (Alliance)-N9831.
First Author: Aixa Elena Soyano
Poster
2013 ASCO Annual Meeting
AFM11, a CD19/CD3 bispecific tandab, to facilitate T-cell-mediated killing of CD19+ cells.
First Author: Eugene Zhukovsky
